載入...
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
Prostate cancer (PCa) is the most widely diagnosed male cancer in the Western World and while low- and intermediate-risk PCa patients have a variety of treatment options, metastatic patients are limited to androgen deprivation therapy (ADT). This treatment paradigm has been in place for 75 years due...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5325456/ https://ncbi.nlm.nih.gov/pubmed/27487144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10901 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|